George · The Biohack Diaries
Young Blood Plasma
Young blood plasma treatment involves infusing plasma, the liquid part of blood, from a young donor into an older person. It has gained attention in recent years for its potential health benefits: factors in young blood plasma may promote tissue repair and regeneration, support the immune system and reduce inflammation, with possible improvements in cognitive function, muscle strength and overall vitality. Research is still ongoing, but the potential benefits are considerable, and we were the first clinic to offer this treatment.
Our young blood plasma comes from a single screened newborn cord-blood donor and is cross-matched to you 1–3 days before treatment. It is rich in the growth factors of young blood. The infusion takes 45 minutes, and a doctor and a critical-care nurse stay with you throughout. Results come quickly, bringing energy and a general sense of wellbeing.
What it is and how it works
Why umbilical cord blood
We chose umbilical cord blood as the source of our young blood plasma because it offers the purest and youngest blood available, without any disturbance to the donor's health. Newborn umbilical cord blood is exceptionally rich in stem cells, stem cell exosomes and growth factors. It is untouched by environmental pollution, because the newborn has spent the whole of gestation in the protected environment of the mother's womb, and it has not been affected by any of the negative effects of aging.
Each newborn provides one umbilical cord, filled with young blood. While others may use this blood for stem cell culture, we use it to produce our young blood plasma. And while other places may use young blood from young adults, we use umbilical cord blood, an even younger and more valuable resource. Compared with adult plasma, umbilical cord plasma is even richer in regenerative proteins and growth factors, which makes our approach safer, more potent and biologically younger than therapies using adult plasma.
What young blood plasma contains
Young blood plasma is believed to contain many factors that may benefit anti-aging treatment. Key components studied for their potential anti-aging effects include:
Growth factors: proteins that play a crucial role in cell growth, tissue repair and regeneration. They can stimulate cellular activity, helping to rejuvenate aging tissues and promote overall health.
Exosomes: tiny vesicles released by cells that carry bioactive molecules such as proteins and genetic material, which may deliver beneficial signals that promote cellular health and function.
Cytokines, immunomodulatory proteins and antibodies, which may enhance the immune response in older people.
Clotting and repair agents.
Anti-inflammatory molecules, thought to help reduce chronic inflammation, a significant factor in age-related disease.
Neuroprotective factors: substances that may protect brain cells from damage and degeneration, potentially benefiting cognitive function and brain health.
These proteins decline with age, and early research has shown that replenishing them can help enhance brain function, improve physical recovery and reduce inflammation. Young plasma works by replacing lost growth factors, giving a rapid infusion of youthful proteins.
What it is for
Young blood plasma is rich in the growth factors of young blood and is used for rejuvenation and to maintain good health. Its potential benefits include:
Rejuvenation and tissue repair. Factors in young plasma may promote tissue repair and regeneration and help reverse age-related degenerative changes in organs and tissues.
Cognitive function. Improvements in memory, attention and mental clarity.
Muscle strength and mobility. Growth factors may trigger cellular regeneration and support muscle repair, improving mobility and physical capability.
Immune support. Better ability to fight off infections and a lower risk of certain diseases.
Reduced inflammation. Chronic inflammation is linked to many age-related conditions, including cardiovascular disease, dementia and arthritis.
Cardiovascular health. Rejuvenating factors may support blood-vessel health and circulation.
Bone and joint health. Growth factors may stimulate bone regeneration and cartilage repair.
Energy and wellbeing. Results are fast, offering energy and a general sense of wellbeing.
Who it is for
Young blood plasma is particularly suited to:
People with chronic fatigue or mental fog
Patients recovering from viral illness or immune stress
Those starting an anti-aging program and looking for a metabolic reset
Anyone looking for a mild, low-risk entry into regenerative therapy
Adults seeking an advanced, long-term anti-aging plan, including patients over 60
Our international patients come from Singapore, the UAE, Australia, Hong Kong, the U.S. and elsewhere. Your doctor will advise whether young blood plasma, stem cell therapy or a combination of the two best fits your condition, goals and timeline.
The treatment
The infusion takes 45 minutes.
Cross-match (1–3 days before). As this is a blood product, we first take a blood sample to cross-match with, and select, the most suitable young blood plasma donor for you. The cross-match checks ABO compatibility and test-tube compatibility, similar to the Coombs test used in blood transfusion. This process usually takes 1–3 days before treatment can go ahead.
Your laboratory certificate. On the day, you receive a laboratory certificate detailing the plasma used, including blood group, infectious-disease test results and cross-match details.
The infusion. You receive a single-donor young blood plasma infusion of about 50–55 ml through an IV line over 45 minutes. A doctor and an experienced critical-care nurse stay with you and oversee the entire process.
Many patients report feeling the effects within the first week after the session, and benefits generally appear within 1–2 weeks. You can have young blood plasma every 6 months to 1 year; to enjoy its anti-aging effects and maintain good health, we generally recommend it once a year. The number of sessions is always set by your doctor after an in-person assessment, and several treatments can be combined on the same day, as your doctor advises.
Before and aftercare
No special aftercare is required. The medical team is happy to give you personalized advice based on your individual needs.
Quality and safety
Our attention to quality begins before the baby is born:
Carefully selected mothers. We select only young, healthy mothers who meet our strict criteria during antenatal care.
Healthy, full-term newborns. We use umbilical cord blood only from healthy full-term newborns (preterm and post-term births are excluded).
Single, screened donor. Each treatment uses plasma from a single screened donor, collected under strict ethical and sterile protocols and under full medical oversight.
Lab class 100. Each donor's plasma is processed and stored in our Lab class 100 laboratory, a standard known for producing purified medications for injection and advanced nanotechnology.
Blood-bank protocols. We follow the same standardized protocols as international blood banks to ensure the quality and safety of our plasma.
Cross-matched to you. Every infusion is cross-matched to your blood 1–3 days beforehand.
Full documentation. You receive a laboratory certificate showing the blood group, infectious-disease test results and cross-match details. Screening and certification follow Thai Ministry of Public Health requirements, and all biologics are processed in Ministry of Public Health-approved laboratories, with documentation available for every treatment.
Supervised throughout. A doctor trained in anti-aging medicine and immunology and a critical-care nurse stay with you for the whole infusion, in a sterile infusion room with monitored protocols and follow-up afterwards.
The science
Parabiosis: where the idea began
Parabiosis is the surgical joining of two living organisms, often two mice, so that their circulatory systems become connected. In anti-aging research, parabiosis experiments connect an older mouse with a younger one. The idea is that the blood of young organisms may contain factors with rejuvenating effects on older ones, so by sharing a circulation with a younger partner, the older animal could benefit from the regenerative properties of young blood.
Older mice connected to younger mice have shown improvements in several age-related conditions, including better muscle function, enhanced cognitive abilities and increased stem cell activity. These changes suggest that young blood may have beneficial effects on the aging process.
What research has found
Improved cognitive function. Older mice given young blood plasma showed improvements in cognitive function and memory, thought to be related to factors in young blood that support brain health and neuroplasticity (Villeda et al., 2011).
Enhanced tissue regeneration. Young blood plasma in older mice has been associated with improved muscle function and tissue regeneration, suggesting that young blood contains factors that promote tissue repair and rejuvenation (Conboy et al., 2005).
Reversal of age-related decline. Some research indicates that young blood plasma might counteract age-related declines such as loss of muscle strength and physical performance, by stimulating tissue repair and regeneration (Katsimpardi et al., 2014).
Immunomodulatory effects. Young blood plasma has been linked to potential immune benefits, including increased immune-cell activity and an improved response to infection (Chen et al., 2014).
Neuroprotective effects. Animal studies suggest young blood plasma may protect brain cells from damage and degeneration associated with aging (Castellano et al., 2017). Human umbilical plasma proteins have been shown to promote central nervous system repair (Castellano JM et al., "Human Umbilical Plasma Proteins Promote CNS Repair", Nature, 2021; see also Wyss-Coray T., "Young Blood for Old Brains", Nature, 2016).
Function in the aging population
As we age, muscle mass and strength decline, reducing mobility and independence. Young blood plasma has shown promise in enhancing muscle strength and function: its growth factors may trigger cellular regeneration and support muscle repair, improving mobility and physical capability in older adults.
Cognitive decline affects memory, attention and decision-making. Neuroprotective factors in young plasma may protect brain cells from damage, supporting better cognitive performance and mental clarity.
Cardiovascular health is vital for overall function and wellbeing. Studies suggest young blood plasma may have positive effects on the cardiovascular system, as its rejuvenating factors may promote blood-vessel health and improve circulation.
The immune system weakens with age, making older adults more susceptible to infections and disease. Young blood plasma has been associated with immune rejuvenation, as its immune-regulating substances may enhance the immune response.
Osteoporosis and joint stiffness are common in older people and limit function and mobility. Young blood plasma has shown potential to promote bone density and joint health, as its growth factors may stimulate bone regeneration and cartilage repair.
Taken together, this emerging research offers exciting possibilities for enhancing function and quality of life in older people, and as research continues, young blood plasma may become a transformative way to promote healthy aging.
Aging diseases
Aging brings health challenges such as cognitive decline, muscle weakness and impaired tissue repair. Young blood plasma may promote tissue repair and regeneration by stimulating stem cell activity and the release of growth factors, which could have significant implications for age-related conditions such as osteoporosis and muscle atrophy. In animal studies, it has been found to enhance cognitive function and memory. It has been linked to modulation of immune responses, potentially revitalizing the aging immune system, and may reduce the chronic inflammation associated with arthritis and cardiovascular disease. With age, the brain's neuroplasticity declines and its vulnerability to neurodegenerative disease grows; young blood plasma has shown the ability to protect brain cells from damage, potentially slowing the progression of conditions such as Alzheimer's and Parkinson's disease.
Alzheimer's disease
Alzheimer's disease is a progressive neurodegenerative disorder that affects millions of people worldwide, causing memory loss, cognitive decline and impaired daily functioning. There is no cure, and young blood plasma is one of the promising avenues being researched:
Cognitive function. Animal studies have shown promising results for young plasma on cognitive function in Alzheimer's disease. Factors in young plasma may enhance neuroplasticity, improving memory and learning. Studies have reported a potential reduction in amyloid-beta plaques, a hallmark of Alzheimer's disease, after young blood plasma treatment, suggesting it may help preserve cognitive function and slow disease progression.
Neuroprotection and synaptic regeneration. Young plasma is thought to contain factors that shield brain cells from oxidative stress and inflammation, and it may stimulate synaptic regeneration and improve connections between nerve cells.
Anti-inflammatory effects. Chronic inflammation in the brain is associated with the progression of Alzheimer's disease. Young plasma may modulate the immune response and reduce this inflammation.
Neuronal survival. Emerging evidence suggests young plasma may support the survival and regeneration of neurons, helping to preserve brain structure and function.
This preclinical research is promising, but animal studies may not translate directly to humans, and comprehensive, rigorous clinical trials are needed before these findings can be applied clinically.
Young blood plasma and stem cells: complementary, not competing
Young blood plasma and stem cell therapy are two front-runners in anti-aging and regenerative medicine. Both have shown promising results in reducing inflammation, improving organ function and slowing signs of aging, and patients often ask whether they are alternatives or can work together.
Mesenchymal stem cell (MSC) therapy uses undifferentiated cells that can become different tissue types (bone, cartilage, fat and even nerve). These cells also secrete bioactive molecules that suppress inflammation, repair damaged tissue, modulate immune responses and enhance communication between cells. Stem cells are used for joint degeneration, autoimmune conditions, lung disease and chronic fatigue, and are a cornerstone of systemic anti-aging treatment. Our stem cells are umbilical-cord-derived, xeno-free and grown in a Lab class 100 laboratory, with a Certificate of Analysis.
The main differences:
Source: young blood plasma comes from a screened young donor; stem cell therapy uses umbilical-cord-derived MSCs.
Main mechanism: young plasma replaces lost growth factors; stem cells regenerate and repair tissue.
Onset of results: 1–2 weeks for young plasma; 2–6 weeks for stem cells.
Duration of benefits: young plasma gives a temporary boost (1–3 months); stem cell benefits last longer (6–18 months).
Ideal for: young plasma suits cognitive aging, fatigue and an immune reset; stem cells suit joint pain, chronic inflammation and repair.
Stem cell therapy is best for patients with joint degeneration or osteoarthritis, people with autoimmune or inflammatory diseases, those looking for long-term tissue repair and cellular health, and people who have had success with plasma or PRP and want deeper results.
In many cases the two work even better together. Young plasma provides a rapid infusion of youthful proteins, while stem cells act over a longer time to repair damage, restore function and rebalance the immune system. Combined, they may offer faster reduction of inflammation, better tissue oxygenation and neuroprotection, enhanced healing of aging tissues, and synergistic support for immune resilience and energy. The doctors often recommend a stacked protocol: young plasma first for immediate rejuvenation, followed by stem cells for deep tissue recovery and long-term maintenance.
References:
Castellano JM et al. "Human Umbilical Plasma Proteins Promote CNS Repair." Nature, 2021.
Wyss-Coray T. "Young Blood for Old Brains." Nature, 2016.
Thai FDA. "Guidelines for Stem Cell and Plasma Therapy." Ministry of Public Health, 2023.
Frequently asked questions
Where does the cord blood for your young blood plasma come from?
We source it from a private clinic in Bangkok. Under our contract with the laboratory, the clinic's name and the identity of the donors remain confidential.
How often can I have young blood plasma?
You can have young blood plasma every 6 months to 1 year. We generally recommend once a year to maintain its anti-aging effects. Your doctor sets your schedule after an in-person assessment.
Why do I need a cross-match first?
Because this is a blood product, your blood is cross-matched with the donor plasma to confirm ABO and test-tube compatibility, similar to the Coombs test used in blood transfusions. The cross-match is done 1–3 days before your treatment, so please allow for this when planning your visit.
Is young blood plasma safe for patients over 60?
Yes. It is low-risk and well tolerated across age groups, and all donors are thoroughly screened.
Can I have young blood plasma and stem cells on the same day?
Yes, depending on your condition and your doctor's recommendation. Some patients benefit from combined treatment in one visit.
Do you treat international patients?
Yes. We specialize in caring for international patients, with English-speaking staff, remote consultation and personalized planning.
George writes about his own experience with this on Young blood plasma.
← All treatments in the Healthspan Library